On May 15th, 2020, AzurRx BioPharma, Inc. (NASDAQ:AZRX) filed its first quarter 2020 10-Q with the SEC for the three month period ending March 31, 2020. Highlights year to date include the appointment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback